A novel PKD1 variant demonstrates a disease-modifying role in trans with a truncating PKD1 mutation in patients with Autosomal Dominant Polycystic Kidney Disease

Hamad Mohamed Ali Yaseen, Naser Hussain, Medhat Naim, Mohamed Zayed, Fahd Al-Mulla, Elijah O. Kehinde, Lauren M. Seaburg, Jamie L. Sundsbak, Peter C. Harris

Research output: Contribution to journalArticle

7 Citations (Scopus)

Abstract

Background: Autosomal Dominant Polycystic Kidney Disease (ADPKD) is the most common form of Polycystic Kidney Disease (PKD) and occurs at a frequency of 1/800 to 1/1000 affecting all ethnic groups worldwide. ADPKD shows significant intrafamilial phenotypic variability in the rate of disease progression and extra-renal manifestations, which suggests the involvement of heritable modifier genes. Here we show that the PKD1 gene can act as a disease causing and a disease modifier gene in ADPKD patients. Methods: Clinical evaluation of a family with ADPKD was performed to diagnose and assess disease progression in each individual. PKD1 was genotyped in each individual by targeted sequencing. Results: Targeted screening analysis showed that the patients with ADPKD in the family had the PKD1: p.Q2243X nonsense mutation. A more severe disease phenotype, in terms of estimated Glomerular Filtration Rate (eGFR) and total kidney volume, was observed in two patients where in addition to the mutation, they carried a novel PKD1 variant (p.H1769Y). Other patients from the same family carrying only the (p.Q2243X) mutation showed milder disease manifestations. Conclusion: ADPKD shows significant intrafamilial phenotypic variability that is generally attributed to other modifier genes. In this rare case, we have shown that a variant at PKD1, in trans with the PKD1 mutation, can also act as a modifier gene in ADPKD patients. Understanding the molecular mechanism through which the gene exerts its disease modifying role may aid our understanding of the pathogenesis of ADPKD.

Original languageEnglish
Article number26
JournalBMC Nephrology
Volume16
Issue number1
DOIs
Publication statusPublished - 1 Dec 2015

Keywords

  • ADPKD
  • eGFR
  • ESRD
  • Genetic modifier
  • Novel variant
  • PKD
  • PKD1
  • Polycystic kidney disease

Fingerprint Dive into the research topics of 'A novel PKD1 variant demonstrates a disease-modifying role in trans with a truncating PKD1 mutation in patients with Autosomal Dominant Polycystic Kidney Disease'. Together they form a unique fingerprint.

  • Cite this